Skip to content

Can Psychotherapy Reduce Sickness Absence?

Can Psychotherapy Reduce Sickness Absence?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01181635
Enrollment
400
Registered
2010-08-13
Start date
2010-08-31
Completion date
2022-12-31
Last updated
2019-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Disorders

Brief summary

The purpose of this study is to examine if psychotherapy can reduce sickness absence.

Detailed description

Sickness absence due to psychiatric problems is considered a growing problem in Norway. Little research is done to examine if psychotherapy can reduce sickness absence. Since 2007 there is a government sponsored program in Norway (Raskere tilbake) aimed at reducing sickness absence. This study examines if psychotherapy within this program, delivered at an out-patient clinic, actually reduces sickness absence. Levels of absenteeism is measured before, after and 6 months after treatment. This is a quasi-experimental study, where the treatment-group will be compared with a statistical group in the general population, that is socio-demographical similar and has similar history of sickness absence but haven't been to treatment. Changes in levels of symptoms and quality of life will also be measured. The participants will be asked to describe their working environment, and this will be related to outcome-measures.

Interventions

BEHAVIORALPsychotherapy

Standard psychotherapy for psychiatric disorders.

Sponsors

Lovisenberg Diakonale Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients receiving psychotherapy at Lovisenberg DPS/Raskere Tilbake

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Sickness absenceBefore, after and 6 months after treatment.Present status (working or sick).

Secondary

MeasureTime frameDescription
Psychiatric symptomsBefore, after and 6 months after treatment.CORE-OM.
Quality of life (QALY)Before, after and 6 months after treatment.15 D

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026